Evidence map›Paper›PMID 32419263›Full record

ArticleBrain pathology (Zurich, Switzerland)2020

Differential diagnosis of vacuolar myopathies in the NGS era.

Dorothea Mair, Saskia Biskup, Wolfram Kress, Angela Abicht, Wolfgang Brück, Sabrina Zechel, Karl Christian Knop, Fatima Barbara Koenig, Shelisa Tey, Stefan Nikolin and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. TheActa myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2024
    Review
  5. Current biomarkers in inclusion body myositis.Journal of neuromuscular diseases · 2024
    Review
  6. Review
  7. Review
  8. [Neuropathology I: muscular diseases].Pathologie (Heidelberg, Germany) · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Recent data and developments in myositis.Brain pathology (Zurich, Switzerland) · 2021
    Article
  16. Neuromuscular disease: 2021 update.Free neuropathology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Dorothea MairInstitute of Neuropathology, RWTH Aachen University, Aachen, Germany.
Saskia BiskupCentre for Genomics and Transcriptomics CeGaT, Tübingen, Germany.
Wolfram KressInstitute of Human Genetics, University Würzburg, Würzburg, Germany.
Angela AbichtMedical Genetics Centre MGZ, Munich, Germany.
Wolfgang BrückInstitute of Neuropathology, Göttingen University, Göttingen, Germany.
Sabrina ZechelInstitute of Neuropathology, Göttingen University, Göttingen, Germany.
Karl Christian KnopNeurologie Neuer Wall, Hamburg, Germany.
Fatima Barbara KoenigInstitute of Pathology, Klinikum Kassel, Kassel, Germany.
Shelisa TeyInstitute of Neuropathology, RWTH Aachen University, Aachen, Germany.
Stefan NikolinInstitute of Neuropathology, RWTH Aachen University, Aachen, Germany.
Katja EggermannInstitute of Human Genetics, RWTH Aachen University, Aachen, Germany.
Ingo KurthInstitute of Human Genetics, RWTH Aachen University, Aachen, Germany.
Andreas Ferbert *Department of Neurology, Kassel School of Medicine, Klinikum Kassel, Kassel, Germany.
Joachim Weis *Institute of Neuropathology, RWTH Aachen University, Aachen, Germany.ORCID 0000-0003-3280-6773
RWTH Aachen University · DEKlinikum Kassel · DEUniversity of Göttingen · DECeGaT (Germany) · DEHamburg Institut (Germany) · DEMedical Genetics Center · DEUniversity of Würzburg · DE

Funding

Deutsche Forschungsgemeinschaft INST 948/41-1 FUGGDeutsche Gesellschaft für MuskelkrankeGerman Ministry of Science and Education (BMBF-MND-Net) 360644Interdisciplinary Centre for Clinical Research, RWTH Aachen University (IZKF Aachen) N7-4
6 · The paper itself

Abstract

Altered autophagy accompanied by abnormal autophagic (rimmed) vacuoles detectable by light and electron microscopy is a common denominator of many familial and sporadic non-inflammatory muscle diseases. Even in the era of next generation sequencing (NGS), late-onset vacuolar myopathies remain a diagnostic challenge. We identified 32 adult vacuolar myopathy patients from 30 unrelated families, studied their clinical, histopathological and ultrastructural characteristics and performed genetic testing in index patients and relatives using Sanger sequencing and NGS including whole exome sequencing (WES). We established a molecular genetic diagnosis in 17 patients. Pathogenic mutations were found in genes typically linked to vacuolar myopathy (GNE, LDB3/ZASP, MYOT, DES and GAA), but also in genes not regularly associated with severely altered autophagy (FKRP, DYSF, CAV3, COL6A2, GYG1 and TRIM32) and in the digenic facioscapulohumeral muscular dystrophy 2. Characteristic histopathological features including distinct patterns of myofibrillar disarray and evidence of exocytosis proved to be helpful to distinguish causes of vacuolar myopathies. Biopsy validated the pathogenicity of the novel mutations p.(Phe55*) and p.(Arg216*) in GYG1 and of the p.(Leu156Pro) TRIM32 mutation combined with compound heterozygous deletion of exon 2 of TRIM32 and expanded the phenotype of Ala93Thr-caveolinopathy and of limb-girdle muscular dystrophy 2i caused by FKRP mutation. In 15 patients no causal variants were detected by Sanger sequencing and NGS panel analysis. In 12 of these cases, WES was performed, but did not yield any definite mutation or likely candidate gene. In one of these patients with a family history of muscle weakness, the vacuolar myopathy was eventually linked to chloroquine therapy. Our study illustrates the wide phenotypic and genotypic heterogeneity of vacuolar myopathies and validates the role of histopathology in assessing the pathogenicity of novel mutations detected by NGS. In a sizable portion of vacuolar myopathy cases, it remains to be shown whether the cause is hereditary or degenerative.

Indexed as

AdultDiagnosis, DifferentialExome SequencingFemaleGenetic TestingHigh-Throughput Nucleotide SequencingHumansLysosomal Storage DiseasesMaleMiddle AgedMuscular DiseasesMutationPhenotypeautophagyFSHDglycogenin 1muscular dystrophymyofibrillar myopathynext generation sequencing (NGS)Pompe diseasesarcotubular myopathyTRIM32vacuolar myopathy

Identifiers

PMID32419263
PMCPMC8017999
OpenAlexW3026394077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.